We are glad to invite you to the EAP Spring Meeting 2022, scheduled to take place from 13 – 14 May 2022. Read more about Malta here.
The meeting was postponed twice since 2020 due to the pandemic, but this year we plan to finally meet at the Grand Excelsior hotel, nestled between the 16th century bastion walls of Valletta, the capital of Malta and a UNESCO World Heritage site. This is the perfect location and time to continue the mission of the European Academy of Paediatrics (EAP): to promote child health and to harmonize standards of paediatric training and services throughout Europe (and beyond!). Join us to discover new knowledge, promote research and ensure continuing professional development.
Now, more than ever, we need to support each other, and show that the welfare of children should transcend national boundaries and politics. In this increasingly fragmented society, there is no better forum than the EAP Spring Meeting to share knowledge, experience and expand personal contacts with colleagues across Europe and beyond.
We urge you to participate and to help us form a strong and unified team, working for the advancement of our children’s health. See you there!
Guided Valletta Cultural Tour (on foot) followed by light refreshments
Your Enquiries Are Welcome
We will respond to you by Email
Core-MD Project
Coordinating Research and Evidence for Medical Devices (CORE-MD)
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.